Robert G. McNeil Ph.D. has over thirty four years of experience as an active investor and management participant in seed and early-stage biomedical companies. He founded Sanderling Ventures in 1979 and has served since then as a Managing Director of Sanderling's seven investment partnerships. Dr. McNeil was the seed investor for several companies that are the bases of the practice of modern medicine including Advanced Cardiovascular Systems (the basis of Guidant Corp.) and Ventritex (the basis of rhythm management of St. Jude Medical). Over the ensuing years Dr. McNeil has been the founder, Chief Executive Officer of many portfolio companies successfully developed by Sanderling Ventures which continue to define the treatment of human disorders.  In each case the ability to develop a close relationship with management and careful understanding of the companies’ technologies have allowed successful development of products at very early stage. Dr. McNeil earned his Ph.D. in the fields of molecular biology, biochemistry and genetics in 1972 from the University of California.